Prevalence and predictors of metabolic syndrome in rheumatoid arthritis
DOI:
https://doi.org/10.18203/2320-6012.ijrms20173179Keywords:
Metabolic syndrome, Rheumatoid arthritisAbstract
Background: Rheumatoid arthritis (RA) is associated with increased cardiovascular morbidity and mortality secondary to accelerated atherosclerosis. There is a strong association of metabolic syndrome (MS) with atherosclerosis. The objective of this study was to assess the prevalence of MS in RA and to identify the predictors of MS in RA.
Methods: The study included 100 patients of RA (83 females,17 males; median age 42.5(17) years diagnosed according to 2010 American College of Rheumatology-European League Against Rheumatism classification criteria who were on treatment and 110 age and sex-matched apparently healthy controls (26 males, 84 females; median age 45 (20) years). The frequency of MS was assessed using joint consensus 2009 criteria. Patients were also assessed in terms of disease activity, using disease activity score 28 CRP. Logistic regression was used to identify predictors of MS in RA.
Results: Metabolic syndrome was found in 45% of RA group and 22.7% of control group according to joint consensus 2009 criteria (p<0.005). RA group was significantly more likely to have low high-density lipoprotein (65%), elevated blood pressure (60%) levels and abnormal sugar (28%). In RA group, CRP (odds ratio: 1.101, confidence interval: 1.032-1.174 (p=0.004) {adjusted for age, DAS 28 score & Anti-CCP} remained independent predictor for presence of MS in RA.
Conclusions: The frequency of MS was higher in RA group compared to control group. High CRP remained independent predictor associated with presence of MS. There was no association of high disease activity with MS in our RA patients. These findings suggest that the treating physician should screen RA patients early for presence of MS.
Metrics
References
Rall LC, Roubenoff R. Rheumatoid cachexia: metabolic abnormalities, mechanisms and interventions. Rheumatol. 2004;43:1219-23.
Giles JT, Bartlett SJ, Andersen RE, Fontaine KR, Bathon JM. Association of body composition with disability in rheumatoid arthritis: impact of appendicular fat and lean tissue mass. Arthritis Rheum. 2008;59:1407-415.
Callahan LF, Pincus T. Mortality in the rheumatic diseases. Arthritis Care Res. 1995;8:229-41.
Abbasi F, Brown BW, Lamendola C, McLaughlin T, Reaven GM. Relationship between obesity, insulin resistance, and coronary heart disease risk. J Am Coll Cardio. 2002;40:937-43.
Peters MJ, Symmons DP, McCarey D, Dijkmans BA, Nicola P, Kvien TK, et al. EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis. Ann Rheum Dis. 2010;69:325-31.
Reilly MP, Rader DJ. The metabolic syndrome: more than the sum of its parts? Circulat. 2003;108:1546-51.
Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med. 1998;15:539-53.
Executive summary of the third report of the national cholesterol education program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III). JAMA. 2001;285:2486-97.
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome: a new worldwide definition. Lancet. 2005;366:1059-62.
Prevoo ML, van’t Hof MA, Kupper HH, van Leeuwen MA, van de Putte LB, van Riel L. Modified disease activity scores that includes twenty-eight joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 1995;38:44-8.
Physical status the use and interpretation of anthropometry: in report of a WHO expert committee. World Health Organ Tech Rep Ser. 1995;854:1-452.
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International diabetes federation task force on epidemiology and prevention; National heart, lung, and blood institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulat. 2009;120:1640-5.
Mishra A, Chowbey P, Makkar BM, Vikram NK, Wasir JS, Joshi SR, et al. Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management. J Assoc Physician India. 2009;57:163-7.
Stevens RJ, Douglas KM, Saratzis AN, Kitas GD. Inflammation and atherosclerosis in rheumatoid arthritis. Expert Rev Mol Med. 2005;7:1-24.
Dao HH, Do QT, Sakamoto J. Increased frequency of metabolic syndrome among Vietnamese women with early rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2010;12:R218.
Rostom S, Mengat M, Lahlou R, Hari A, Bahiri R, Hajjaj-Hassouni N. Metabolic syndrome in rheumatoid arthritis: case control study. BMC Musculoskelet Disord. 2013;14:147.
Mok CC, Ko GT, Ho LY, Yu KL, Chan PT, To CH. Prevalence of atherosclerotic risk factors and the metabolic syndrome in patients with chronic inflammatory arthritis. Arthritis Care Res (Hoboken). 2011;63:195-202.
Sahebari M, Goshayeshi L, Mirfeizi Z, Rezaieyazdi Z, Hatef MR, Mobarhan MG, et al. Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. Scientific World J. 2011;11:1195-205.
Karvounaris SA, Sidiropoulos PI, Papadakis JA, Spanakis EK, Bertsias GK, Kritikos HD, et al. Metabolic syndrome is common among middle-to-older aged Mediterranean patients with rheumatoid arthritis and correlates with disease activity: a retrospective, cross-sectional, controlled, study. Ann Rheum Dis. 2007;66:28-33.
Zonana-Nacach A, Santana-Sahagun E, Jimenez-Balderas FJ, Coronel C. Prevalence and factors associated with metabolic syndrome in patients with rheumatoid arthritis and systemic lupus erythematosus. J Clin Rheumatol. 2008;14:74-7.
Dessein PH, Tobias M, Veller MG. Metabolic syndrome and subclinical atherosclerosis in rheumatoid arthritis. J Rheumatol. 2006;33:2425-32.
Raterman HG, van Eijk IC, Voskuy AE, Peter MJ, Dijkmans BA, van Halm VP, et al. The metabolic syndrome is amplified in hypothyroid rheumatoid arthritis patients: a cross-sectional study. Ann Rheum Dis. 2010;69:39-42.
Toms T, Panoulas V, John H, Douglas KM, Kitas GD. Methotrexate therapy associates with reduced prevalence of the metabolic syndrome in rheumatoid arthritis patients over the age of 60- more than just an anti-inflammatory effect? A cross sectional study. Arthritis Res Ther. 2009;11(4):R110.
Elkan AC, Hakansson N, Frostegard J, Cederholm T, Hafstrom I. Rheumatoid cachexia is associated with dyslipidemia and low levels of atheroprotective natural antibodies against phosphorylcholine but not with dietary fat in patients with rheumatoid arthritis: a cross-sectional study. Arthritis Res Ther. 2009;11(4):R37.
Chung CP, Oeser A, Solus JF, Avalos I, Gebretsadik T, Shintani A. Prevalence of the metabolic syndrome is increased in rheumatoid arthritis and is associated with coronary atherosclerosis. Atherosclerosis. 2008;196:756-6.
Pandey PK, Swami A, Biswas TK, Thakuria R. Prevalence of metabolic syndrome in treatment naïve rheumatoid arthritis and correlation with disease parameters. Arch Rheumatol. 2017;32(10):1-7.
Sharma A, Bhilave N, Sharma K, Varma I. Metabolic syndrome in Indian patients with rheumatoid arthritis and its correlation with disease activity. Arthritis Res Ther. 2012;14 (Suppl 1):P66.
Georgiadis AN, Papavasiliou EC, Lourida ES, Alamanos Y, Kostara C, Tselepis AD, et al. Atherogenic lipid profile is a feature characteristic of patients with early rheumatoid arthritis: effect of early treatment e a prospective, controlled study. Arthritis Res Ther. 2006;8:R82.
Hassen Zrour S, Hassine Neffeti F, Sakly N, Jguirim M, Korbaa W, Younes M, et al. Lipid profile in Tunisian patients with rheumatoid arthritis. Clin Rheumatol. 2011;30:1325-31.
Dursunolu D, Evrengül H, Polat B, Tanriverdi H, Cobankara V, Kaftan A, et al. Lp(a) lipoprotein and lipids in patients with rheumatoid arthritis: serum levels and relationship to inflammation. Rheumatol Int. 2005;25:241-5.
Alexander CM, Landsman PB, Grundy SM. The influence of age and body mass index on the metabolic syndrome and its components. Diabetes Obes Metab. 2008;10:246-50.
Downloads
Published
How to Cite
Issue
Section
